Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis
DAG 18:1 20:4 and 18:0 20:4 concentrations in plasma of patients with mastocytosis and healthy controls. DAG 18:1 20:4 (a) and DAG 18:0 20:4 (b) concentrations in healthy controls and mastocytosis patients. DAG 18:1 20:4 and DAG 18:0 20:4 concentrations in healthy females and males (c, d) and in mastocytosis females and males (e, f).
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.